To The Moon

3/6/2023 Market Diary

1. Market continue its thrust as all major indexes closed with sizable gains but more money are rotated into value areas that has been left out of recent rally. Value outperformed growth at all levels.

2. Some significance in Friday's close that could support a sustained rally going forward,

i) RSP $Invesco S&P 500 Equal Weight ETF(RSP)$ +2.18% broke out of 5 months downtrend line at highest volume YTD,

ii) IWM $iShares Russell 2000 ETF(IWM)$ +3.63% broke out of 4 months box range,

iii) Spike up in short term breath with MMTW crossing above 50% bullish bias threshold since 17/5 iv) Lowest new lows logged since 8/2.

3. Highlighted ARGT $Global X MSCI Argentina ETF(ARGT)$ equities are grinding higher as ARGT ETF attempt a multi-month base breakout

4. Focus and Stalk list are filled with speculative small and micro caps beneath pivot, mostly from XBI $Spdr S&P Biotech Etf(XBI)$ group but opportunities could be lucrative in short term.

5. A contrarian view to this market action, a profit taking rally.

6. Focus: $Pyxis Oncology, Inc.(PYXS)$ $Immunogen(IMGN)$ $Mersana Therapeutics Inc.(MRSN)$ $SAB Biotherapeutics, Inc.(SABS)$ $Spectrum Pharmaceuticals(SPPI)$ $BridgeBio Pharma, Inc.(BBIO)$ $Alto Ingredients, Inc.(ALTO)$ $Nano Labs Ltd.(NA)$

Image

This aggressive price action has flooded my entire scans with speculative small and microcap stocks, particularly those in $Spdr S&P Biotech Etf(XBI)$ $iShares Biotechnology ETF(IBB)$ , that has been resting beneath their pivotal levels for weeks. It is what it is.

Image